SCHEDULE 13G: Systematic Financial Management LP Discloses 6.15% Passive Stake in AngioDynamics Inc.

Systematic Financial Management LP has reported a passive beneficial ownership of 6.15% in AngioDynamics Inc., holding 2,521,066 shares as of February 13, 2025.

Summary

• Systematic Financial Management LP, a New Jersey-based investment adviser, has filed a Schedule 13G indicating beneficial ownership in AngioDynamics Inc.
• The filing reports that Systematic Financial Management LP beneficially owns an aggregate of 2,521,066 shares of AngioDynamics Inc. common stock.
• This ownership represents 6.15% of the class of securities, based on the information provided in the filing.
• Systematic Financial Management LP holds sole voting power over 1,484,876 shares and sole dispositive power over all 2,521,066 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing (Schedule 13G) disclosing a passive ownership stake, which typically carries a neutral sentiment as it does not convey operational or financial performance, nor does it suggest activist intent.

Positives

• The disclosure of a significant passive stake by an institutional investor like Systematic Financial Management LP can be viewed as a vote of confidence in AngioDynamics Inc.'s long-term prospects.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding AngioDynamics Inc.'s future financial performance or strategic direction.

Industry Context

This filing is a routine disclosure of an institutional investor's passive ownership stake in a publicly traded company within the medical device sector. It does not provide insights into broader industry trends or competitive dynamics, but rather reflects an investment decision by a specific fund.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by an institutional investor may be perceived as a positive signal, potentially increasing investor confidence in the company.

Key Dates

Keywords

AngioDynamics Inc., Systematic Financial Management LP, Schedule 13G, beneficial ownership, institutional investor, passive stake, medical devices, healthcare